Hit enter to search or ESC to close
AsclepiX Therapeutics
Menu
  • About
    • Our Team
  • Technology
  • Pipeline
  • Media Center
    • News
    • Publications
  • Careers
  • Contact Us
    • About
      • Our Team
    • Technology
    • Pipeline
    • Media Center
      • News
      • Publications
    • Careers
    • Contact Us
    Daily Archives

    January 6, 2020

    News

    AsclepiX Therapeutics, Inc. Expands Leadership Team with Appointment of Industry Leader Theresa Heah, MD, MBA as Chief Medical Officer.

    Recent Posts

    • AsclepiX Therapeutics, Inc. Appoints Robert J. Dempsey as Chief Executive Officer and President
    • AsclepiX Therapeutics, Inc. Doses First Patient in Phase 1/2a Trial of AXT107 Intravitreal Self-Forming Gel Depot Peptide for Diabetic Macular Edema (DME)
    • AsclepiX Therapeutics to Present at Solebury Trout Private Company Showcase on October 15, 2020
    • AsclepiX Therapeutics Announces $35 Million Series A Financing
    • AsclepiX Therapeutics, Inc. Expands Leadership Team with Appointment of Industry Leader Theresa Heah, MD, MBA as Chief Medical Officer.

    Recent Comments

      Asclepix Therapeutics Logo White

      New Jersey Office

      AsclepiX Therapeutics, Inc.
      185 Hudson Street, Suite 2500
      Jersey City, New Jersey 07311

      Contact Us

      Baltimore Office

      Corporate Headquarters
      301 W 29th Street, Suite 2004,
      Baltimore, Maryland 21211

      Contact Us

      © 2021 AsclepiX Therapeutics. All Rights Reserved. Privacy Policy | Terms of Use